• Radiotherapy Plans Based on Machine Learning Being Used to Treat Localized PC Patients
  • Erleada-ADT Combo Increases Survival of mCSPC Patients Without Affecting Quality of Life, Phase 3 Trial Shows
  • Long-term Hormone Therapy Does More Harm than Good in Prostate Cancer Patients with Low PSA Levels After Surgery, Analysis Shows
  • Liproca Depot Shows Promise for Treatment of Early-Stage Prostate Cancer
  • $35M Gift from Benioffs to Support Prostate Cancer Research Initiative at UCSF
  • Zejula Granted FDA’s Breakthrough Therapy Status for Treating Metastatic Castration-resistant Prostate Cancer
  • Jevtana Delays Disease Progression, Prolongs Survival in Men with mCRPC, Phase 4 Trial Shows
  • Higher Radiation Therapy Doses Over Shorter Time Show No Added Side Effects in Men with Prostate Cancer, Study Says
  • Erleada Cuts Risk of Death by 25% in Localized Castration-resistant Prostate Cancer, Phase 3 Trial Finds
  • Focal Therapy, AuroLase, Shows Good Safety and Potential Effectiveness in Pilot Clinical Trial
  • Eating Mushrooms May Prevent Prostate Cancer, Japanese Study Suggests
  • Prolaris Helps to ID Prostate Cancer Patients Suited for Active Surveillance, Study Says